2022
Removing Race From Hyperbilirubinemia Guidelines Is Not Enough
Ostfeld-Johns S, Aragona E, Hart L. Removing Race From Hyperbilirubinemia Guidelines Is Not Enough. JAMA Pediatrics 2022, 176: 1163-1164. PMID: 36251301, DOI: 10.1001/jamapediatrics.2022.3865.Commentaries, Editorials and Letters
2024
A Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research
Sieger M, Morin J, Budris L, Sienna M, Ostfeld-Johns S, Hart L, Morosky C. A Comparison of Two Statewide Datasets to Understand Population Prevalence of Substance Use in Pregnancy: Findings and Considerations for Policy & Research. Maternal And Child Health Journal 2024, 28: 1121-1131. PMID: 38539033, PMCID: PMC11060901, DOI: 10.1007/s10995-024-03914-6.Peer-Reviewed Original ResearchConceptsSubstance use disordersSubstance useBlack mothersPregnancy-related deathsFederal Child Abuse PreventionMental health conditionsPublic health aimSelf-reported drug useMaternal self-reportDrug usePrevalence of substance useChild protective services involvementProtective services involvementMothers self-reportedChild abuse preventionSelf-reported dataStatistically similar ratesPrenatal substance exposureSelf-report ratingsHealth aimRate of whitesHispanic mothersHealth conditionsHospital personnelSelf-report
2023
Race and the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline—Reply
Ostfeld-Johns S, Aragona E, Hart L. Race and the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline—Reply. JAMA Pediatrics 2023, 177: 437-437. PMID: 36780144, DOI: 10.1001/jamapediatrics.2022.5910.Commentaries, Editorials and Letters